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Abstract 
Background: Anthocyanins are major constituents of food colours and have been reported to possess anti-diabetic 
activities for potential medicinal use. The precise role of anthocyanins in diabetic nephropathy is poorly understood. 
We investigated whether anthocyanin-rich Seoritae extract (SE) can potentially prevent oxidative stress and lipotox-
icity, which are the main causes of renal damage in diabetic nephropathy, via activation of AMP-activated protein 
kinase (AMPK) and the consequent effects on its target molecules.
Methods: Four groups of male C57BLKS/J db/m and db/db mice were used. Diabetic and non-diabetic mice were 
orally administered 10 mg/kg body weight SE daily for 12 weeks, starting at 8 weeks of age.
Results: db/db mice treated with anthocyanins showed decreased albuminuria. Anthocyanins ameliorated intra-
renal lipid concentrations in db/db mice with improvement of glomerular matrix expansion and inflammation, which 
was related to increased phosphorylation of AMPK and activation of peroxisome proliferator-activated receptor (PPAR) 
α and PPARγ, and inhibited the activity of acetyl-CoA carboxylase and sterol regulatory element-binding protein 1. 
Anthocyanins reversed diabetes-induced increases in renal apoptosis and oxidative stress. In cultured human glomer-
ular endothelial cells, anthocyanins prevented high glucose-induced oxidative stress and apoptosis through activa-
tion of AMPK in the same manner.
Conclusions: The results revealed that anthocyanins ameliorated diabetic nephropathy in db/db mice via phos-
phorylation of AMPK, the major energy-sensing enzyme, and the consequent effects on its target molecules, which 
appeared to prevent lipotoxicity-related apoptosis and oxidative stress in the kidney.
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Background
Diabetic nephropathy is the leading cause of end-stage 
renal disease and is a growing global health problem. 
Despite developments in pharmacological strategies 
to modulate diabetes, diabetic nephropathy remains a 
major microvascular complication in many patients with 
diabetes. However, there is still insufficient understand-
ing about the full mechanisms involved in progressive 
diabetic renal disease. One of the causal factors for 
the progression of diabetic kidney injury is lipotoxic-
ity. Increasing evidence suggests that renal ectopic lipid 
accumulation and dysregulated lipid metabolism in the 
kidney are involved, in part, in the pathophysiology of 
diabetic nephropathy [1, 2].
Anthocyanins, flavonoids within the polyphenol class, 
are most abundant in various coloured fruits, vegeta-
bles, red wine, and grains, and possess a basic skeleton 
of 2-phenylbenzopyrylium or flavylium glycoside [3, 4]. 
Anthocyanins are the most oxidized flavonoids with a 
fully unsaturated C ring and a hydroxyl at position 3, and 
are potential therapeutic agents as antioxidants [5]. Their 
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mechanisms of action have been investigated in numer-
ous experimental models in vivo and in vitro. Interest has 
focused on their potential antioxidant activity, which is 
proposed as a key mechanism for the prevention of many 
chronic diseases including metabolic disorders and can-
cer [6–9]. Anthocyanins have potential antidiabetic activ-
ity to protect against pancreatic cell damage and improve 
insulin sensitivity, and have a potent therapeutic effect 
on diabetic complications such as diabetic retinopathy 
[10, 11]. However, it has barely been established whether 
these natural compounds have beneficial effects on the 
pathogenesis of diabetic nephropathy.
Adenosine monophosphate-activated protein kinase 
(AMPK) is a crucial metabolic energy sensor involved 
in a wide range of biological activities that normalise 
lipid, glucose, and energy imbalances [12]. AMPK is acti-
vated by low energy status (AMP/ATP ratio) and is dys-
regulated in patients with metabolic syndromes such as 
diabetes and obesity. It has been reported that AMPK 
is abundantly expressed in the kidney and its activity is 
reduced in the diabetic kidney [13]. Experimental evi-
dence suggests that AMPK activation attenuates lipotox-
icity, reactive oxygen species generation, inflammation, 
and endothelial dysfunction in type 2 diabetes [13–15].
The collective results favour the view that anthocyanins 
have beneficial effects on lipid metabolism dependent on 
activation of the AMPK pathway in metabolic disorders 
including type 2 diabetes, obesity, and non-alcoholic fatty 
liver disease [4, 16]. Anthocyanins ameliorate hypergly-
caemia and insulin resistance via activation of AMPK, 
with inactivation of acetyl-CoA carboxylase (ACC) in 
hepatocytes, white adipose tissue, and skeletal muscle in 
diabetic animal models [17].
We hypothesised that anthocyanin-rich Seoritae 
extract (SE; Glycine max L.) may ameliorate renal oxida-
tive stress and lipotoxicity, which are the principal causes 
of renal damage in diabetic nephropathy, via activation 
of AMPK and the consequent effects on its target mol-
ecules. Glomerular endothelial dysfunction is commonly 
the initiating insult that predisposes tissue to injury in 
diabetes [18]. We evaluated the effects of anthocyanins 
on high glucose-induced oxidative stress and apoptosis 
related to AMPK activation and its downstream mol-
ecules in cultured human glomerular endothelial cells 
(HGECs).
Methods
Preparation of SE and analysis of anthocyanins in SE
The SE used was produced by the following method. 
Seoritae samples (1,500 g) were extracted with 12,000 mL 
of 30% ethanol for 3 h at 90–100°C. The solution was fil-
tered twice through 50 and 1-µm filters and concentrated 
in a vacuum evaporator (60°C) to 70 brix. The residual 
solvent was removed in a drying machine for 18  h at 
60°C in a vacuum. The resulting powder was stored in 
a plastic bag until use. The anthocyanin content in SE 
was analysed by HPLC using a Dionex Ultimate 3000 
series dual low-pressure ternary gradient pump (Dionex 
Softron GmbH, Germering, Germany) and an Ultimate 
3000 series photodiode array detector for anthocyanin 
analysis. The crude anthocyanin extract was analysed 
by its HPLC chromatogram. Three principal anthocya-
nin peaks were detected in the chromatogram by diode 
array detection at 530 nm. The major anthocyanins were 
identified as delphinidin-3-O-glucoside (25.2%), cyani-
din-3-O-glucoside (68.3%), and petunidin-3-O-glucoside 
(6.5%) by comparison with the HPLC retention times of 
standard compounds, as previously described [19].
Experimental methods
Male 6-week-old C57BLKS/J db/m and db/db mice were 
purchased from Jackson Laboratories (Bar Harbor, ME, 
USA). The mice were fed a regular chow diet, provided 
with water ad  libitum, and allowed to acclimatise for 
1  week before experiments. The mice were divided into 
four groups. Control db/m mice (n  =  6) and control 
db/db mice (n =  6) received drinking water only, while 
anthocyanin db/m mice (n = 8) and anthocyanin db/db 
mice (n =  8) received 10 mg/kg body weight anthocya-
nin-rich SE daily for 12 weeks. For measurement of 24-h 
urinary albumin, the mice were placed in individual 
mouse metabolic cages (Nalgene, Rochester, NY, USA) 
every 4 weeks. At week 20, the mice were anaesthetised 
by intraperitoneal injection of a mixture of Rompun 
(10  mg/kg; Bayer Korea, Ansan, Gyeonggi-Do, Korea) 
and Zoletil (30 mg/kg; Virbac, Carros, France). Blood was 
collected from the left ventricle and centrifuged, and the 
resulting plasma was stored at −70°C for analyses. The 
kidneys were rapidly dissected and stored in 10% buff-
ered formalin for immunohistochemical analyses. HbA1c 
was measured from red cell lysates by HPLC (Bio-Rad, 
Richmond, CA, USA). Triglyceride and total cholesterol 
concentrations were determined using an automatic ana-
lyser (Model 917; Hitachi, Tokyo, Japan) and commercial 
kits (Wako, Osaka, Japan). NEFA levels were measured 
with a JCA-BM1250 automatic analyser (JEOL, Tokyo, 
Japan).
Ethics statement
All animal experiments were in accordance with the 
Laboratory Animals Welfare Act, Guide for the Care 
and Use of Laboratory Animals, and Guidelines and 
Policies for Rodent Experiments provided by the Insti-
tutional Animal Care and Use Committee at the School 
of Medicine, The Catholic University of Korea (Approval 
No. YEO20131601FA). All procedures complied with 
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the Guide for the Care and Use of Laboratory Animals 
(National Institutes of Health Publication No. 85–23, 
revised 1996).
Assessment of albuminuria, renal oxidative stress, 
and intra‑renal lipid content
Twenty-four-hour urine collection for measurement of 
albuminuria was performed using metabolic cages (Nal-
gene) at week 20, and urinary albumin concentrations 
were obtained by immunoassay (Bayer, Elkhart, IN, USA). 
To evaluate oxidative stress, we measured 24-h urinary 
8-epi-prostaglandin F2α (OxisResearch, Foster City, CA, 
USA). Intra-renal lipids were extracted using the method 
of Bligh and Dyer with slight modifications [20].
Light microscopy study
Kidney samples were fixed in 10% buffered formalin 
and embedded in paraffin. Histology was assessed after 
periodic acid-Schiff staining. The mesangial matrix and 
glomerular tuft were quantified for each glomerular 
cross-section, as previously reported [21]. More than 30 
glomeruli, cut through the vascular pole, were counted 
per kidney, and the average of the measured areas was 
used for analysis.
Immunohistochemistry for TGF‑β1, type IV collagen, 
and TUNEL assay
For immunohistochemistry, 4-μm-thick sections were 
deparaffinised, hydrated in ethanol, treated with an anti-
gen-unmasking solution containing 10  mmol/L sodium 
citrate buffer (pH 6.0), and washed with PBS. The sec-
tions were incubated with 3% H2O2 in methanol to block 
endogenous peroxidase activity, and then with 10% nor-
mal goat serum in PBS to block non-specific binding. 
The sections were incubated overnight with anti-TGF-β1 
(1:100; R&D Systems, Minneapolis, MN, USA) and anti-
COL IV (1:200; Biodesign International, Saco, ME, USA) 
antibodies in a humidified chamber at 4°C. The bound 
antibodies were localised with a peroxidase-conjugated 
secondary antibody using a Vector Impress Kit (Vector 
Laboratories, Burlingame, CA, USA) and 3,3-diamin-
obenzidine substrate solution. Finally, the sections were 
dehydrated in ethanol, cleared in xylene, mounted with-
out counterstaining, and examined in a blinded manner 
using light microscopy (Olympus BX-50; Olympus Opti-
cal, Tokyo, Japan).
For quantification of proportional areas of staining, 
~20 views (×400 magnification) were randomly located 
in the renal cortex and corticomedullary junction of each 
section and images were taken. The images were analysed 
to determine the density X-positive area/glomerular total 
area using a computer image analysis program (Scion 
Image Beta 4.0.2; Frederick, MD, USA).
Detection of apoptotic cells in formalin-fixed, paraffin-
embedded tissue was performed by in situ TUNEL using 
an ApopTag In Situ Apoptosis Detection Kit (Chemicon-
Millipore, Billerica, MA, USA). The TUNEL reaction 
was assessed in a whole glomerular biopsy under ×400 
magnification.
Western blot analysis
Total protein from renal cortical tissues was extracted 
with Pro-Prep Protein Extraction Solution (Intron Bio-
technology, Gyeonggi-Do, Korea), following the manu-
facturer’s instructions. Protein concentrations were 
determined using the Bradford reagent (Bio-Rad Labo-
ratories, Hercules, CA, USA). Western blot analysis 
was performed to further confirm the responses using 
antibodies recognising specific epitopes. Proteins were 
separated by SDS-PAGE, transferred to nitrocellulose 
membranes, and detected with the following antibod-
ies: anti-phosphorylated (phospho)-Thr172 AMPK (Cell 
Signaling Technology, Danvers, MA, USA), anti-total 
AMPK (Cell Signaling Technology), anti-peroxisome 
proliferator-activated receptor (PPAR) α (Abcam, Cam-
bridge, UK), anti-PPARγ, anti-phospho-ACC (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA), anti-total 
ACC (Santa Cruz Biotechnology), anti-sterol regulatory 
element-binding protein 1 (SREBP-1; Santa Cruz Bio-
technology), anti-B cell leukaemia/lymphoma 2 (BCL-2; 
Santa Cruz Biotechnology), anti-BCL-2-associated X 
protein (BAX; Santa Cruz Biotechnology), and anti-β-
actin (Sigma-Aldrich, St Louis, MO, USA). After wash-
ing, the membranes were incubated with anti-mouse IgG 
or anti-rabbit IgG horseradish peroxidase (HRP)-linked 
secondary antibodies (Cell Signaling Technology) or a 
rabbit anti-goat IgG HRP-peroxidase secondary antibody 
(Sigma-Aldrich). The membranes were developed using 
an ECL Plus Detection Kit (Amersham International, 
Buckinghamshire, UK) to produce chemiluminescence 
signals, which were captured on X-ray films. Band den-
sities were quantified with Quantity One software (Bio-
Rad Laboratories).
Cell culture and small interfering RNA (siRNA) transfection
HGECs were purchased from Anigio-Proteomie (Bos-
ton, MA, USA) and subcultured in endo-growth media 
(Angio-Proteomie). After treatment with medium con-
taining different concentrations of d-glucose (5 mmol/L 
d-glucose (low glucose), 40 mmol/L d-glucose (high glu-
cose), or 5 mmol/L d-glucose plus 35 mmol/L mannitol 
(osmotic control)) and 1, 10, or 50  µg/mL anthocyanin 
for 6  h, western blotting was performed for phospho-
Thr172 AMPK, total AMPK, PPARα, PGC-1α, ERR-1α, 
PPARγ, phospho-ACC, total ACC, superoxide dismutase 
(SOD)-1, SOD-2, BCL-2, BAX, and β-actin with specific 
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antibodies. To examine the effects of anthocyanins on 
other renal cells in high-glucose medium, we also used 
cultured NMS2 mesangial cells (see Additional file 1 for 
further details).
siRNAs targeted toward Ampkα1, Ampkα2, and Sirt1, 
and a non-specific scrambled siRNA (siRNA control) 
were complexed with a transfection reagent (Lipo-
fectamine 2000; Invitrogen, Carlsbad, CA, USA), accord-
ing to the manufacturer’s instructions. The sequences of 
the siRNAs were: α1-AMPK, 5′-GCAUAUGCUGCAG 
GUAGAU-3′; α2-AMPK, 5′-CGUCAUUGAUGAUGAG 
GCU-3′; SIRT1, 5′-CACCUGAGUUGGAUGAUAU-3′; 
and scrambled siRNA, 5′-CCUACGCCACCAAUU 
UCGU-3′ (Bioneer, Daejeon, Korea). At 24 h after trans-
fection, HGECs were exposed to 40 mmol/L glucose and 
50 µg/mL anthocyanins for 24 h.
Statistical analysis
Data are expressed as mean ±  SD. Differences between 
groups were examined for statistical significance by 
ANOVA with the Bonferroni correction using SPSS 
version 19.0 (IBM Corp., Armonk, NY, USA). Values of 
p < 0.05 were considered statistically significant.
Results
Physical and biochemical characteristics of mice
Body weight was heavier in the diabetic mouse groups 
compared with the non-diabetic mouse groups (Table 1). 
Blood glucose, HbA1C, serum triglyceride, NEFA, total 
cholesterol, and amount of food eaten were higher in 
db/db mice than in db/m mice. db/db mice showed a 
significant increase in albuminuria compared with db/m 
mice. Anthocyanin treatment ameliorated serum NEFA, 
triglyceride, total cholesterol, and albuminuria in db/db 
mice (Table 1).
Effects of anthocyanin on renal phenotype, TGF‑β1, 
and type IV collagen
There were no differences in the fractional mesan-
gial areas between db/m and db/m anthocyanin mice 
(Figure  1a–d, m). There was a marked increase in the 
mesangial area in db/db mice compared with db/m mice 
(p < 0.01). Consistent with the changes in the mesangial 
fractional area, expression of the pro-fibrotic growth fac-
tor TGF-β1, which is associated with extracellular matrix 
type IV collagen, was significantly increased in db/db 
mice compared with db/m and db/m anthocyanin mice 
(Figure 1e–l, n–o). All diabetes-induced renal phenotypic 
changes and inflammation in db/db mice improved with 
anthocyanin treatment.
Renal cortical expression of phospho‑Thr172 AMPK, total 
AMPK, PPARα, PPARγ, total ACC, phospho‑ACC, SREBP‑1, 
and intra‑renal NEFA, triglyceride, and total cholesterol
Western blotting showed that diabetes markedly 
decreased the phospho-AMPK Thr172/total AMPK 
ratio in db/db mice compared with db/m and db/m 
anthocyanin mice (Figure  2a). Anthocyanin treatment 
restored the phospho-AMPK Thr172/total AMPK ratio 
in db/db mice to the levels in db/m and db/m anthocy-
anin mice (Figure  2a, b; p  <  0.05). The levels of PPARα 
and PPARγ were lower in db/db mice compared with 
db/m and db/m anthocyanin mice, as assessed by west-
ern blotting, and improved with anthocyanin treatment 
(Figure 2a, c, d; p < 0.01). The phospho-ACC/total ACC 
ratio and SREBP-1 level were evaluated to determine the 
changes in lipid metabolism as target proteins of AMPK. 
A decrease in the phospho-ACC/total ACC ratio and an 
increase in the SREBP-1 level were seen in db/db mice, 
and were restored with anthocyanin treatment (Figure 2a, 
e, f; p < 0.01).
Table 1 Physical and biochemical characteristics of the control and diabetic mice with or without anthocyanin treatment 
at the end of the 12-week experimental period
Data are mean ± SD (n = 6–8 per group).
FBS fasting blood sugar.
* p < 0.05 and ** p < 0.001 compared with the other groups.
db/m control db/m ATC db/db control db/db ATC
Body weight (g) 31.6 ± 2.2 31.3 ± 1.9 59.8 ± 5.7** 41.4 ± 5.1**
Kidney weight (g) 0.2 ± 0.01 0.2 ± 0.02 0.26 ± 0.01* 0.24 ± 0.04*
Food intake (g/d) 1.2 ± 1.1 1.3 ± 0.8 4.0 ± 0.1** 5.7 ± 2.1**
FBS (mg/dL) 136 ± 21 142 ± 17 577 ± 49** 552 ± 66**
HbA1c (%) 4.1 ± 0.1 3.9 ± 0.3 13.0 ± 1.2** 11.8 ± 2.5**
NEFA (mEq/L) 1.01 ± 0.08 0.98 ± 0.08 1.92 ± 0.25** 1.04 ± 0.13
Triglycerides (mg/dL) 40.1 ± 8.9 20.8 ± 9.8 71.9 ± 13.7** 28.0 ± 20.0
Total cholesterol (mg/dL) 26.6 ± 5.9 30.3 ± 1.8 41.8 ± 9.4* 29.4 ± 2.6
24-h albuminuria (µg) 11.4 ± 2.9 4.4 ± 2.7 169.4 ± 74.5** 62.0 ± 37.0
Urine volume (mL) 0.4 ± 0.5 0.4 ± 0.4 10.6 ± 4.9** 10.7 ± 4.2**
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Direct measurement of intra-renal lipid concentra-
tions showed increases in the NEFA, triglyceride, and 
total cholesterol concentrations, consistent with PPARα, 
PPARγ, phospho-ACC/total ACC ratio, and SREBP-1, 
which were ameliorated with anthocyanin treatment 
(Figure 2g–i; p < 0.05).
Renal expression of pro‑apoptotic BAX, anti‑apoptotic 
BCL‑2, and TUNEL‑positive cells
The BAX protein levels were increased in db/db mice 
compared with db/m and db/m anthocyanin mice, as 
observed by western blotting (Figure 3a). The BCL-2 pro-
tein levels were decreased in db/db mice compared with 
db/m and db/m anthocyanin mice (Figure  3a). Conse-
quently, the BCL-2/BAX ratio was significantly decreased 
in db/db mice. Anthocyanin treatment of db/db mice 
increased the BCL-2 protein levels and decreased the 
BAX protein levels, resulting in a normalised ratio of 
BCL-2/BAX expression (Figure 3b; p < 0.01).
There was a significant increase in the number of 
TUNEL-positive cells in the glomeruli of db/db mice 
compared with db/m and db/m anthocyanin mice. The 
number of TUNEL-positive cells in db/db mice was 
decreased after anthocyanin treatment (Figure  3c–g; 
p < 0.01).
Effects of anthocyanin on renal 24‑h urinary 8‑isoprostane 
concentrations
Increases in renal oxidative stress and lipid peroxidation 
were observed in db/db mice compared with db/m and 
db/m anthocyanin mice with respect to urinary 8-iso-
prostane concentrations (Figure  4; p  <  0.01). The 24-h 
Figure 1 Changes in glomerular phenotypes in anthocyanin-treated db/db mice. Glomerular mesangial fractional area, TGF-β1 expression, and 
collagen IV expression in the cortical area of db/m and db/db mice, with or without anthocyanin treatment, were evaluated. a–l Representative 
sections stained with periodic acid-Schiff reagent and representative immunohistochemical staining for TGF-β1 and type IV collagen (original 
magnification ×400). m–o Quantitative analyses of the mesangial fractional area (%) (m), TGF-β1 (fold) (n), and type IV collagen (fold) (o). **p < 0.01 
vs. db/m control, db/m ATC, and db/db ATC mice. Col IV type IV collagen, PAS periodic acid-Schiff stain.
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urinary 8-isoprostane concentration was significantly 
decreased in db/db mice with anthocyanin treatment 
compared with the control groups. Taken together, these 
findings suggest that oxidative stress in db/db mice could 
be ameliorated by anthocyanin treatment.
In vitro studies
We evaluated the effects of anthocyanins on high glucose-
induced oxidative stress and apoptosis related to AMPK 
activation and its downstream molecules in cultured 
HGECs. High glucose (40  mmol/L d-glucose) induced 
significant decreases in the activation of phosphor-Thr172 
AMPK (Figure  5a, b) and PPARα, PGC-1α, and ERR-1α 
levels (Figure 5a, c–e). Consistent with these results, high 
glucose decreased the PPARγ levels and inactivated ACC 
(Figure 5f–h). High glucose also decreased SOD-1, SOD-
2, and anti-apoptotic activity of BCL-2/BAX (Figure 5i–l). 
In contrast, anthocyanins prevented high glucose-induced 
oxidative stress and apoptosis related to the activation of 
AMPK, PPARα–PGC-1α–ERR-1α signalling, PPARγ, and 
inactivation of ACC. When compared with high-glucose 
medium, addition of anthocyanin to low-glucose medium 
Figure 2 Phospho-Thr172 AMPK, total AMPK, PPARα, PPARγ, phospho-ACC, total ACC, SREBP-1, and intra-renal lipid levels in the renal cortex of db/m 
and db/db mice with or without anthocyanin treatment. Protein lysates (30 μg) from the renal cortex were separated by SDS-PAGE and analysed 
by western blotting. a Representative western blots for phospho-Thr172 AMPK, total AMPK, PPARα, PPARγ, phospho-ACC, total ACC, SREBP-1, and 
β-actin. b–f Quantitative analyses for phospho-Thr172 AMPK/total AMPK (b), PPARα/β-actin (c), PPARγ/β-actin (d), phospho-ACC/total ACC (e), and 
SREBP-1/β-actin (f). *p < 0.05 and **p < 0.01 vs. db/m control, db/m ATC, and db/db ATC mice. g–i Quantitative analyses of intra-renal NEFA (g), 
triglyceride (h), and total cholesterol (i) concentrations. *p < 0.05 and **p < 0.01 vs. db/m control, db/m ATC, and db/db ATC mice.
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did not affect intracellular signalling and glomerular 
endothelial cells.
To show whether the anti-apoptotic effect of antho-
cyanins is AMPK-dependent in diabetes, we performed 
additional experiments using siRNAs for AMPKΑ1, 
AMPKΑ2, and SIRT1 in cultured HGECs (Figure 6a–d). 
Transfected siRNAs for AMPKΑ1 and AMPKΑ2 sup-
pressed anthocyanin-induced AMPK and PPARα–
PGC-1α–ERR-1α signalling compared with the siRNA 
control group. However, transfection with the siRNA for 
Sirt1 only suppressed SIRT1, and not the phospho-Thr172 
AMPK/total AMPK ratio and PPARα–PGC-1α–ERR-1α 
signalling (Figure 6e–j).
Discussion
The present results suggest that anthocyanin-rich 
SE ameliorated renal function and phenotype in the 
Figure 3 Anti-apoptotic BCL-2, pro-apoptotic BAX, and TUNEL assays in the renal cortex of db/m and db/db mice with or without anthocyanin 
treatment. Protein lysates (10 μg) from the renal cortex were separated by SDS-PAGE and analysed by western blotting. a Representative western 
blots of BCL-2, BAX, and β-actin levels. b Quantitative analyses of the BCL-2/BAX ratio. c–g Representative immunohistochemical staining for TUNEL-
positive cells in db/m control (c), db/m ATC (d), db/db control (e), and db/db ATC (f) mice, and quantitative analyses of the results (g). **p < 0.01 vs. 
db/m control, db/m ATC, and db/db ATC mice.
Figure 4 Twenty-four-hour urinary 8-isoprostane concentrations in 
db/m and db/db mice with or without anthocyanin treatment. The 
24-h urinary 8-isoprostane concentrations of the mice are shown. 
**p < 0.01 vs. db/m control, db/m ATC, and db/db ATC mice.
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Figure 5 Effect of anthocyanins on intracellular signalling, apoptosis, and oxidative stress in HGECs cultured in low-glucose (5 mmol/L d-glucose) 
or high-glucose (40 mmol/L d-glucose) medium with or without anthocyanin treatment (50 μg/mL). Phospho-Thr172 AMPK, total AMPK, PPARα, 
PGC-1α, ERR-1α, PPARγ, phospho-ACC, total ACC, and β-actin levels were assessed using cultured HGECs. Protein lysates (10 μg) were separated by 
SDS-PAGE and analysed by western blotting. a Representative western blots and quantitative analyses of phospho-Thr172 AMPK, total AMPK, PPARα, 
PGC-1α, ERR-1α, and β-actin. b–e Quantitative analyses of phospho-Thr172 AMPK/total AMPK (b), PPARα (c), PGC-1α (d), and ERR-1α (e). f–h Repre-
sentative western blots of PPARγ, phospho-ACC, total ACC, and β-actin in HGECs (f) and quantitative analyses of the results g, h. i–l Representative 
western blots of SOD-1, SOD-2, BCL-2, BAX, and β-actin levels in HGECs (i) and quantitative analyses of the results (j–l). *p < 0.05 and **p < 0.01 
compared with high-glucose medium. HG high glucose, LG low glucose.
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Figure 6 Effect of AMPKα1, AMPKα2, and SIRT1 siRNAs on anthocyanin-stimulated AMPK signalling in HGECs. Protein lysates (10 μg) from cul-
tured HGECs were separated by SDS-PAGE and analysed by western blotting. Cultured HGECs were transfected with 40 nmol/L control siRNA or 
40 nmol/L AMPKα1, AMPKα2, or SIRT1 siRNAs using a transfection reagent (Lipofectamine 2000). At approximately 24 h after transfection, the levels 
of phospho-AMPK Thr172, total AMPK, SIRT1, and PGC-1α signalling in low-glucose medium were analysed. a–d Representative western blots (a) and 
quantitative analyses of the results b–d. *p < 0.05 and **p < 0.01 compared with the other groups. Cultured HGECs were transfected with 50 nmol/L 
control siRNA or 50 nmol/L AMPKΑ1, AMPKΑ2, or SIRT1 siRNAs and stimulated with anthocyanin in high-glucose medium. At approximately 24 h 
after stimulation, the levels of phospho-AMPK Thr172, total AMPK, SIRT1, PPARα, PGC-1α, and ERR-1α signalling in high-glucose medium were 
analysed. e–j Representative western blots of phospho-AMPK Thr172, total AMPK, PPARα, PGC-1α, ERR-1α, and β-actin levels (e) and quantitative 
analyses of the results (f–j). *p < 0.05 and **p < 0.01 compared with high-glucose medium. HG high glucose.
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examined mouse model of type 2 diabetes, and was 
related to renal lipid accumulation, apoptotic renal 
cell injury, and oxidative stress through restoration of 
decreased AMPK activity and its target molecules in 
diabetic nephropathy. Downstream regulators of AMPK 
including ACC, SREBP-1, and PPAR were all translated 
into restoration of diabetes-induced lipotoxicity by 
anthocyanins in the mouse model and in  vitro experi-
ments. Using siRNAs for AMPKΑ1 and AMPKΑ2 in 
HGECs, we observed beneficial effects of anthocyanins 
on lipotoxicity in an AMPK-dependent manner.
The ultrasensitive energy sensor AMPK activates the 
catabolic pathway, inhibits the anabolic pathway, and 
restores energy homeostasis by phosphorylating multi-
ple substrates in many metabolic syndrome-associated 
diseases [13, 15, 22, 23]. Among the target molecules of 
AMPK, ACC is related to fatty acid oxidation and inhibi-
tion of fatty acid synthesis in many organs, such as the 
liver and kidneys. Phosphorylation of ACC1 at Ser79 and 
ACC2 at Ser218 by AMPK leads to inhibition of ACC 
activity and decreased malonyl-CoA, which is pivotal in 
controlling the rate of fatty acid β-oxidation. It has been 
reported that the reduced AMPK activity in diabetic 
nephropathy is linked to increased triglyceride accumu-
lation because of reduced inhibitory phosphorylation of 
ACC [15, 24].
SREBP, another target molecule controlled by AMPK, 
is a transcription factor regulating cellular lipogenesis 
and lipid homeostasis. Mammalian SREBP has three iso-
forms (SREBP-1a, SREBP-1c, and SREBP-2) and distinct 
but overlapping lipogenic transcriptional processes [25]. 
The nutrient sensor AMPK negatively regulates SREBP 
to limit lipogenesis by directly phosphorylating SREBP. 
In our previous studies, we found that suppressed AMPK 
and the subsequent increase in SREBP activity in dia-
betic nephropathy lead to lipotoxicity in the pathogenesis 
of diabetic nephropathy [26, 27]. In the present study, 
anthocyanin-mediated AMPK activation increased phos-
phorylation of ACC and decreased SREBP, which were 
correlated with decreased lipid contents in the diabetic 
kidney.
PPARs have noteworthy biological functions as sensors 
for fatty acid derivatives and control important meta-
bolic pathways involved in lipid and energy metabolism 
[28, 29]. Renal PPARα and PPARγ play important roles 
in modulating energy utilisation in the kidney through 
regulation of renal fatty acid oxidation. Stimulation of 
fatty acid oxidation through PPAR activation provides a 
potential mechanism by which the lipid content of tissues 
can be reduced to prevent lipid accumulation. In light 
of this, PPAR upregulation by anthocyanins seems to be 
another therapeutic target for improvement of lipotoxic-
ity in diabetic nephropathy [30–32].
Our in  vitro study demonstrated that another critical 
mediator of the effects of PPARα on lipotoxicity is PGC-1α, 
a coactivator protein that interacts with several transcrip-
tion factors, including ERR-1α, an important mediator in 
mitochondrial biogenesis. Notably, ERR-1α activated by 
PGC-1α induces genes that play roles in lipid transport and 
fatty acid oxidation [33]. Meanwhile, SIRT1 is another mol-
ecule that responds to a variable nutrient status and is con-
sidered an AMPK partner [34]. The results for the siRNA 
for SIRT1 in the present in vitro study suggest that the effect 
of anthocyanins operates in a SIRT1-independent pathway.
The mechanism of lipotoxic injury in diabetic nephropa-
thy could be explained by downregulation of fatty acid oxida-
tion with altered expression related to energy sensor AMPK 
activity and its downstream lipogenic transcription fac-
tors, including PPAR and SREBP-1 [2]. Although this may 
not entirely explain the complex pathogenesis of diabetic 
nephropathy, it has not been explored to its fullest poten-
tial. Recently, some investigators reported that altered renal 
lipid metabolism and accumulation in diabetic nephropathy 
were observed in humans [1]. They clarified that heavy lipid 
deposition and increased intracellular lipid droplets were 
associated with dysregulation of lipid metabolism genes, and 
suggested that renal lipid metabolism may serve as a target 
for specific therapies of human diabetic nephropathy [1, 26].
Anthocyanins are natural phytochemicals and the most 
oxidized flavonoids with a fully unsaturated C ring and a 
hydroxyl at position 3. They can be found as glycosylated 
forms of polyhydroxy and polymethoxy derivatives of 
2-phenylbenzopyrylium, acylated or non-acylated with 
aliphatic acids, thus providing a rich source of potential 
therapeutic agents as antioxidants. Most experimental 
data have verified that anthocyanins serve as antioxidants 
and have anti-inflammatory properties in metabolic dis-
eases. Takikawa et al. showed that anthocyanin-rich bil-
berry extract ameliorates hyperglycaemia and insulin 
sensitivity via AMPK activation in white adipose tissue, 
skeletal muscle, and the liver in type 2 diabetic mice [17, 
35]. These effects were accompanied by inactivation of 
ACC and upregulation of decreased PPARα expression. 
Valenti et al. [4] proposed a possible mechanism for the 
beneficial effects of anthocyanins in non-alcoholic fatty 
liver disease and non-alcoholic steatohepatitis. They 
explained that the effect of anthocyanins on lipid metab-
olism is dependent on activation of the AMPK path-
way and its target molecules, SREBP-1c and PPARα, in 
hepatocytes. In the present study, we found that diabetic 
nephropathy exhibited profound metabolic abnormali-
ties, including increased intra-renal lipid accumulation 
in kidney tissue as well as circulating NEFA and triglyc-
eride concentrations, while all levels were restored with 
anthocyanin treatment via AMPK activation and its tar-
get molecules such as ACC, SREBP-1, and PPAR. Taken 
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together, these results demonstrated that anthocyanins 
improved decreased AMPK activity and the accompany-
ing lipotoxicity in the examined mouse model of diabe-
tes. Further studies are needed to verify the mechanisms.
It is uncertain whether the target of anthocyanins is 
solely AMPK or whether it overlaps with upstream mol-
ecules, such as adiponectin. Little is known about the 
roles of upstream molecules of AMPK such as adiponec-
tin, LKB1, and CaMKKβ in the regulation of AMPK 
in the kidney [36]. Recently, Liu et  al. [3] reported that 
anthocyanins enhance adiponectin secretion from adi-
pose tissue and ameliorate diabetes-related endothelial 
dysfunction. Accordingly, we cannot exclude the possibil-
ity that anthocyanins restore decreased AMPK activity, 
in part, through increased activity of adiponectin [3, 16]. 
Furthermore, we could not determine the specific contri-
butions of the bioactive compounds in SE to the observed 
effects or the amounts of these compounds incorporated 
into the kidney. As cyanidin-3-O-glucoside was the most 
abundant anthocyanin in SE, we cautiously supposed that 
the main therapeutic effect of SE was mediated by cyan-
idin-3-O-glucoside based on previous studies [9, 31], but 
future investigations are required to verify this notion.
We used glomerular endothelial cells under high-glu-
cose conditions in an in vitro study. The results showed 
that the earliest indicator of kidney damage in diabe-
tes is albuminuria, which is widely considered to reflect 
underlying endothelial dysfunction [18]. The overall 
effect of AMPK in the endothelium has been proposed 
as the potential improvement of endothelial dysfunc-
tion, although the specific roles of endothelial AMPK in 
the kidney have not been shown [36]. Considering the 
marked differences in the metabolic profiles of the indi-
vidual cell types within the kidney, it could be important 
to identify the differences in AMPK expression and the 
effects of anthocyanins on other renal cell populations, 
such as podocytes. The results for cultured mesangial 
cells in high-glucose medium with anthocyanin treat-
ments showed similar patterns in the present study 
(Additional file 2).
In conclusion, reduced AMPK activity was associated 
with lipotoxicity, which could be related to apoptosis 
and oxidative stress in diabetic nephropathy. Anthocya-
nins, as new and interesting AMPK activators, attenu-
ated lipotoxicity through inhibition of ACC and SREBP-1 
and restoration of PPARα and PPARγ, which mediated 
the removal of lipid accumulation in the kidney. This 
was accompanied by improvement of glomerular matrix 
accumulation and albuminuria. The data suggest that 
high glucose-induced HGEC damage translated into 
reduced AMPK activity and exacerbated oxidative stress 
and apoptotic cell damage in the diabetic setting. All 
changes were reversed with anthocyanin treatment.
Conclusions
The results of the present study demonstrated that anthocya-
nin-rich SE ameliorated diabetic nephropathy in db/db mice 
via AMPK activation and the consequent effects on its target 
molecules, which appeared to prevent lipotoxicity-related 
apoptosis and oxidative stress in the kidney. In this manner, 
anthocyanins may have a potential therapeutic role in type 
2 diabetic nephropathy. Further clinical investigations are 
needed to evaluate the precise molecular mechanisms of the 
bioactive compounds, including anthocyanins, in SE.
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